作者：
Webb,S.M. [1]
;
Ware,J.E. [2]
;
Forsythe,A. [3]
;
Yang,M. [4]
;
Badia,X. [5]
;
Nelson,L.M. [6]
;
Signorovitch,J.E. [7]
;
McLeod,L. [8]
;
Maldonado,M. [9]
;
Zgliczynski,W. [10]
;
DeBlock,C. [11]
;
Portocarrero-Ortiz,L. ;
Gadelha,M.
作者单位：
Department of Medicine/Endocrinology, Centre for Biomedical Research on Rare Diseases (CIBERER Unit
[1]
IMS Health, Barcelona, Spain
[2]
Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States
[3]
Department of Endocrinology, Diabetology and Metabolism, University Hospital, Antwerp, Belgium
[4]
Division of Endocrinology, Medical School, Federal University of Rio de Janeiro, Rio de Janeiro
[5]
RTI Health Solutions, Research Triangle Park, NC, United States
[6]
National Institute of Neurology and Neurosurgery 'Manuel Velasco Suárez', Mexico City, Mexico
[7]
Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester
[8]
Novartis Pharma AG, Basel, Switzerland
[9]
Analysis Group, Inc., Boston, MA, United States
[10]
Department of Endocrinology, Centre for Postgraduate Medical Education, Warsaw, Poland
[11]
发布时间
2014-09-25
换一批
